INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "METABOLIC BENEFITS OF SELTOREXANT ON PATIENT'S WEIGHT AND INSULIN SENSITIVITY"

GENEVA, April 6 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/IB2025/059598) for "METABOLIC BENEFITS OF SELTOREXANT ON PATIENT'S WEIGHT AND INSULIN SENSITIVITY" on Sep 24, 2025. With publication no. WO/2026/069146, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DREVETS, Wayne (Janssen Research & Development, LLC920 US Route 202Raritan, New Jersey 08869), PANDINA, Gahan (Janssen Research & Development, LLC920 US Route 202Raritan, New Jersey 08869), FLOSSBACH, Yanina (Actelion Ph...